Dw. Giang et al., CLINICAL-DIAGNOSIS OF MULTIPLE-SCLEROSIS - THE IMPACT OF MAGNETIC-RESONANCE-IMAGING AND ANCILLARY TESTING, Archives of neurology, 51(1), 1994, pp. 61-66
Objective: Magnetic resonance imaging, computed tomography, cerebrospi
nal fluid analysis, and evoked potential testing are used to assist in
the diagnosis of patients suspected to have multiple sclerosis (MS).
The impact of these tests on a clinician's diagnosis of patients suspe
cted to have MS has not been studied systematically. Design: Clinician
s made a diagnosis of each patient following clinical evaluation, agai
n after reviewing the results of magnetic resonance imaging, and final
ly after reviewing information from other laboratory testing. These di
agnoses were compared with the criterion standard of a masked ''gold s
tandard'' panel reviewing all information after a mean follow-up of 0.
9 year. Setting: The General Neurology Clinic and Multiple Sclerosis C
linic of the University of Rochester (NY). Patients: A consecutive sam
ple of 62 patients diagnosed as having either possible or probable MS
following clinical evaluation. Main Outcome Measure: Changes in diagno
stic certainty of clinicians following incremental presentation of new
laboratory data and the accuracy of such diagnoses. Results: Clinicia
ns used magnetic resonance imaging findings to diagnose definite MS or
to eliminate MS from diagnostic consideration in 44% of cases. In the
se cases, further laboratory testing did not alter clinicians' decisio
ns. In the remaining 56% of cases, in which magnetic resonance imaging
did not lead to a diagnosis of definite MS or eliminate MS from diagn
ostic consideration, further laboratory testing led to such diagnoses
in an additional 13% of cases. Gold standard diagnoses were in agreeme
nt with the clinician's assessments. Conclusions: Magnetic resonance i
maging aids in the evaluation of patients suspected to have MS; other
subsequent studies (computed tomography, cerebrospinal fluid analysis,
and evoked potential testing) have less impact. After all studies are
performed, about half of such patients still have a tentative diagnos
is.